Buy Recommendation Issued On RPRX By Cowen & Co.
Cowen & Co. analyst issues BUY recommendation for RPRX on July 13, 2026 01:09PM ET. The previous analyst recommendation was Buy.RPRX was trading at $56.15 at issue of the analyst...
Cowen & Co. analyst issues BUY recommendation for RPRX on July 13, 2026 01:09PM ET. The previous analyst recommendation was Buy.RPRX was trading at $56.15 at issue of the analyst...
RBC Capital analyst issues OUTPERFORM recommendation for BSX on July 13, 2026 01:11PM ET. The previous analyst recommendation was Outperform.BSX was trading at $45.22 at issue of the analyst recommendation.The...
Cowen & Co. analyst issues BUY recommendation for CEVA on July 13, 2026 01:13PM ET. The previous analyst recommendation was Buy.CEVA was trading at $44.06 at issue of the analyst...
Noble Capital Markets analyst issues OUTPERFORM recommendation for VIVO on July 13, 2026 01:14PM ET. VIVO was trading at $4.335 at issue of the analyst recommendation.Historical Analyst RecommendationsLatest 10 recommendationsReport...
Cowen & Co. analyst issues HOLD recommendation for LITE on July 13, 2026 01:13PM ET. The previous analyst recommendation was Hold.LITE was trading at $776.329 at issue of the analyst...
RBC Capital analyst issues OUTPERFORM recommendation for JNJ on July 13, 2026 01:14PM ET. The previous analyst recommendation was Outperform.JNJ was trading at $258.31 at issue of the analyst recommendation.The...
Cowen & Co. analyst issues BUY recommendation for LSCC on July 13, 2026 01:14PM ET. The previous analyst recommendation was Buy.LSCC was trading at $132.32 at issue of the analyst...
RBC Capital analyst issues OUTPERFORM recommendation for EW on July 13, 2026 01:13PM ET. The previous analyst recommendation was Outperform.EW was trading at $92.92 at issue of the analyst recommendation.The...
Cowen & Co. analyst issues BUY recommendation for ANET on July 13, 2026 01:12PM ET. The previous analyst recommendation was Buy.ANET was trading at $184.39 at issue of the analyst...
RBC Capital analyst issues OUTPERFORM recommendation for GMED on July 13, 2026 01:15PM ET. The previous analyst recommendation was Outperform.GMED was trading at $79.27 at issue of the analyst recommendation.The...